Director, Chief Medical Officer · TENAX THERAPEUTICS, INC. · Common Stock
Side
BUY
Value
$26K
Shares
2,500
Price
$10.22
Executed
Dec 9, 2025
Disclosed
Dec 10, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 9 executedDec 10, 2025 disclosed
TENX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
4 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Rich Stuart filed this Form 4 reporting a open-market purchase of TENX on Dec 9, 2025. It became public on Dec 10, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Medical Officer
Rich Stuartcik:0001841785
Issuer
TENAX THERAPEUTICS, INC.cik:0000034956
Revision history · 0
No field has changed since this record was first ingested.
